Validity and diagnostic accuracy of the Auditory Consonant Trigram (ACT) Test in Turkish patients with mild cognitive impairment and Alzheimer’s disease
Öz
Purpose: This study is a multi-method validity study aimed to evaluate the clinical usefulness of the Auditory Consonant Trigram (ACT) Test in distinguishing healthy controls, patients with Mild Cognitive Impairment (MCI), and patients with Alzheimer's disease (AD). Materials and Methods: A total of 166 participants aged 50–86 years were included: 22 with AD, 20 with MCI, and 124 healthy controls. All participants first completed a battery of standardized neuropsychological tests, followed by the ACT Test. Results: Significant group differences were found in ACT Test scores, indicating an impairment gradient across delay intervals (Control > MCI > AD). ACT Test total scores correlated moderately to strongly with general cognitive functions, memory, and executive functions. Logistic regression analysis found that ACT Test significantly distinguished patients with AD from controls (OR = 0.89, %95 CI [0.84–0.96]), but did not differentiate patients with MCI from controls (OR = 1.04, %95 CI [0.91–1.19]). In the extended model that included age and other cognitive variables, ACT Test was not an independent predictor. ROC analysis showed strong discrimination for AD (AUC = 0.89, 95% CI [0.83–0.94]) with a cut-off point of ≤ 39, sensitivity of 91% (95% CI [0.71–0.99]), and specificity of 82% (95% CI [0.74–0.89]). Adjusting for age further improved accuracy in the age-adjusted model. Conclusion: The ACT Test provides robust discrimination of AD and shows meaningful convergent associations with multiple cognitive domains.
Anahtar Kelimeler
Alzheimer’s Disease, Mild Cognitive Impairment, Working Memory, Neuropsychological Tests, Roc Curve
Etik Beyan
Kaynakça
- Madnani RS. Alzheimer’s disease: A mini-review for the clinician. Front Neurol. 2023;14:1178588.
- Rasmussen J, Langerman H. Alzheimer’s disease - why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019;9:123-30.
- Ding H, Wang B, Hamel AP, Melkonyan M, Ang TFA et al. Prediction of progression from mild cognitive impairment to Alzheimer’s disease with longitudinal and multimodal data. Front Dement. 2023;2:1271680.
- Öksüz N, Ghouri R, Taşdelen B, Uludüz D, Özge A. Mild cognitive impairment progression and Alzheimer’s disease risk: A comprehensive analysis of 3553 cases over 203 months. J Clin Med. 2024;13:518.
- Daou L, El Alayli A, Constantinos F, Dib G, Barakat M. Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review. Biomark Neuropsychiatry. 2023;9:100069.
- Brown J. Some tests of the decay theory of immediate memory. Q J Exp Psychol. 1958;10:12-21.
- Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exp Psychol. 1959;58:193-8.
- Stuss DT, Stethem LL, Poirier CA. Comparison of three tests of attention and rapid information processing across six age groups. Clin Neuropsychol 1987;1:139-52.
- Stuss DT, Stethem LL, Pelchat G. Three tests of attention and rapid information processing: An extension. Clin Neuropsychol. 1988;2:246-50.
- Bherer L, Belleville S, Peretz I. Education, age, and the Brown-Peterson technique. Dev Neuropsychol. 2001;19:237-51.
